© 2021 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
Increased Risk of Tardive Dyskinesia
How could drugs that block post-synaptic dopamine 2 receptors increase the risk for tardive dyskinesia over time?
John J. Miller, MD, talks about the increased risk of tardive dyskinesia on a synaptic level.
Dr Miller is medical director, Brain Health, Exeter, NH; editor in chief, Psychiatric TimesTM; staff psychiatrist, Seacoast Mental Health Center, Exeter, NH; consulting psychiatrist, Exeter Hospital, Exeter, NH; consulting psychiatrist, Insight Meditation Society, Barre, MA.